Back | Next |
home / stock / vir / vir message board
Subject | By | Source | When |
---|---|---|---|
Full of crap haha | Srhogan1984 | investorshub | 01/27/2021 2:55:41 AM |
* * $VIR Video Chart 01-26-2021 * * | ClayTrader | investorshub | 01/26/2021 11:18:56 PM |
znewcar1: VIR 74% v11,4M c77.38 f127M H78.28 | znewcar1 | investorshangout | 01/26/2021 9:36:20 PM |
Sounds like a short to me. You need | Srhogan1984 | investorshub | 01/26/2021 9:06:52 PM |
Today's move is somewhat scary in the context | DewDiligence | investorshub | 01/26/2021 6:18:52 PM |
VIR(+40% undeservedly, $IMO)on interim phase-1 data for$ VIR-3434 in HBV: | DewDiligence | investorshub | 01/26/2021 6:14:35 PM |
Not really. It's just a phase-2 trial, not | DewDiligence | investorshub | 01/12/2021 2:05:26 PM |
$GILD,$ VIR collaborate on phase-2 HBV trial: | DewDiligence | investorshub | 01/12/2021 2:02:19 PM |
Huge news! | Srhogan1984 | investorshub | 01/12/2021 1:49:06 PM |
What is happening here | Srhogan1984 | investorshub | 09/02/2020 3:39:40 AM |
$VIR starts phase-1 trial of $VIR-3434: | DewDiligence | investorshub | 05/27/2020 2:35:19 PM |
znewcar1: VIR 32% v5,5M c40.10 f117,9M H42.4 gap up then BO R@40.6 dip S@38.1 then HOD and back to S | znewcar1 | investorshangout | 05/18/2020 8:48:27 PM |
* * $VIR Video Chart 05-18-2020 * * | ClayTrader | investorshub | 05/18/2020 8:31:16 PM |
$VIR 1Q20 results3/31/20 cash=$361.8M: | DewDiligence | investorshub | 05/12/2020 8:25:49 PM |
$VIR reports interim phase-2 data in HBV: | DewDiligence | investorshub | 04/15/2020 10:34:58 PM |
nobody pumping this here lol? | Cornball69 | investorshub | 04/13/2020 4:43:14 PM |
Biocentury expounds on$ VIR-$GSK hookup: | DewDiligence | investorshub | 04/07/2020 2:34:58 AM |
znewcar1: VIR 26% v3,6M c36.70 f109,7M PreMH@42 HOD@39.8 S32.25 | znewcar1 | investorshangout | 04/06/2020 8:57:50 PM |
When Glaxo runs a deal with any company, | Pugsieboy | investorshub | 04/06/2020 3:17:12 PM |
When YOU post in any thread $RUN LIKE HELL! | Rocket10 | investorshub | 04/06/2020 3:11:17 PM |
News, Short Squeeze, Breakout and More Instantly...
Vir Biotechnology Inc. Company Name:
VIR Stock Symbol:
NYSE Market:
– Late-breaker SOLSTICE data abstract accepted for poster presentation at the European Association for the Study of the Liver (EASL) Congress 2024 – – Two additional hepatitis program data readouts on track for the fourth quarter 2024 – – $1.51 b...
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Marianne De Backer, M.Sc., Ph.D., MBA, Chief Executive Officer is scheduled to participate in a fireside chat at the BofA Securities Healthcare Conference 2024 on Tuesday, May 14, at 4:20 p.m. PT / 7:20 p.m. ET. A live webcast of the ...
Vir Biotechnology, Inc. (“Vir” or “the Company”, Nasdaq: VIR) today announced the nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors (the “Board”) at its upcoming annual meeting of stockholders on May 29, 2024 (the ...